Effect of Acupuncture on Delayed Emesis for the Patients Who Received High-Emetogenic Chemotherapy with Standard Antiemetic Prophylaxis (KHMC-HO-01): An Open-Label, Randomized Study

Table 1

Baseline characteristics.

		Arm A		Arm C		p value
		N	%	N	%
Age	<65	11	55.0	11	55.0	1.000
	>65	10	45.0	10	45.0
	Median (year)	64		64
Sex	M^a)	2	9.5	2	9.5	1.000
	F^b)	19	90.5	19	90.5
Alcohol	No	21	100	20	95.2	1.000
	Yes	0	0	1	4.8
ECOG PS^c)	Grade 0	5	23.8	6	28.6	1.000
	Grade 1	16	76.2	15	74.4
Comorbidity	No	12	57.1	15	71.4	1.000
	Yes	9	42.9	6	28.6
Chemotherapy	AC^d)-based	18	85.7	19	90.5	1.000
	Cisplatin-based	3	14.3	2	9.5
Aim of treatment	Neoadjuvant	8	38.1	7	33.3	1.000
	Adjuvant	13	61.9	13	61.9
	Palliative	0	0	1	4.8

(a) M, male; (b) F, female; (c) ECOG, Eastern Cooperative Oncology Group performance status; (d) AC, adriamycin (doxorubicin) and cyclophosphamide.